NA01
Commercial- Indications
- gut health
Company intelligence / Profile preview
Nova Aurora
Unknown, Unknown, Unknownnovaaurora.health ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Nova Aurora develops novel, upcycled botanical and fungal-derived ingredients from industry byproducts. Their current offerings include a hemp-derived prebiotic powder targeting gut health and a legal mushroom powder derived from post-extraction psilocybin mushroom biomass. The company positions itself at the intersection of sustainability and innovation in the supplement/wellness space.
- Therapeutic areas
- GastroenterologyOther
- Modalities
- Prebiotic powderMushroom powderFunctional food ingredientsNutraceuticalsNutritional ingredient
- Industry
- Food & Nutrition
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Nova Aurora.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nova Aurora.